The Victorian Supreme Court has formally signed off on a $89 million class action settlement for Thalidomide victims in Australia and New Zealand.
UK company Diageo has agreed to pay compensation to about 100 Thalidomide victims, providing them with care for the rest of their lives.
Diageo owns The Distillers Group which marketed the controversial morning sickness drug in Australia in the late 1950s.
Lawyer Peter Gordon told the court it was a fair and reasonable settlement.
Justice David Beach was told there had been unanimous support for the settlement from the claimants.
“None of the group will die wondering whether their claim was investigated,” Mr Gordon said.
There was a smattering of applause as Justice David Beach officially approved the settlement.
The initial class action accused Diageo and Grunenthal of negligence for allowing the drug to be sold without proper testing and for failing to withdraw the drug from the market when the risks were revealed.
Legal proceedings against Grunenthal have been dismissed.
At no time did Grunenthal accept any wrongdoing on its part.
ABC News (Australia)